Search results for "biomarker"

AI Consortium Launches 7.5 Billion Won Project to Personalize Chronic Pain Rehab for Older Adults

AI Consortium Launches 7.5 Billion Won Project to Personalize Chronic Pain Rehab for Older Adults

"My knee hurts constantly," an older patient might tell their doctor. Yet in many cases, diagnostic imaging like X-rays or magnetic resonance imaging...
Deciphering Ampullary Cancer: Korean Researchers Identify Aggressive Subtype of Rare Disease

Deciphering Ampullary Cancer: Korean Researchers Identify Aggressive Subtype of Rare Disease

Where the bile duct and pancreatic duct meet to drain digestive juices into the duodenum, a rare and elusive malignancy can develop: ampullary...
Combination Therapy: Laennec Achieves Pain Relief with One-Fifth the Steroid Dose in Preclinical Study

Combination Therapy: Laennec Achieves Pain Relief with One-Fifth the Steroid Dose in Preclinical Study

An animal study has revealed that combining GC Green Cross Wellbeing’s human placental hydrolysate treatment, Laennec...
Epigenetic Clocks Claiming to Measure Your 'True Age' Still Lack Scientific Standards

Epigenetic Clocks Claiming to Measure Your 'True Age' Still Lack Scientific Standards

"Chronological age: 50s. Body age: 30s." This tagline has long been attached to celebrities praised for their...
Beyond Diseased Samples: National Biobank to Collect Healthy Organ Tissue from Deceased Donors

Beyond Diseased Samples: National Biobank to Collect Healthy Organ Tissue from Deceased Donors

When a specific gene or protein is expressed at unusually high levels in diseased tissue, determining whether the...
AI Tracks Lung Scarring: 4-Percentage-Point Rise in One Year Signals Danger

AI Tracks Lung Scarring: 4-Percentage-Point Rise in One Year Signals Danger

Researchers have established an artificial intelligence benchmark to quantify the progression of idiopathic pulmonary...
Timing of Immune Cell Entry Dictates Anti-Cancer Defense in Hard-to-Treat Brain Tumors

Timing of Immune Cell Entry Dictates Anti-Cancer Defense in Hard-to-Treat Brain Tumors

Some immune cells surrounding a tumor actively attack it, while others create conditions that help it survive.
Olix Obesity Candidate Reduces Monkeys’ Visceral Fat by 29.2%, Outperforming Global Rival

Olix Obesity Candidate Reduces Monkeys’ Visceral Fat by 29.2%, Outperforming Global Rival

Olix announced on July 30 that its obesity drug candidate, "OLX501A," significantly outperformed a global rival...
Novartis Halts Lu-NeoB Development After Early Clinical Data Fall Short

Novartis Halts Lu-NeoB Development After Early Clinical Data Fall Short

Novartis has discontinued the development of Lu-NeoB, an experimental cancer therapy designed to seek out tumor cells...
The Blood Cancer Decoy: Why Some Lymphoma Patients Stop Responding to Treatment

The Blood Cancer Decoy: Why Some Lymphoma Patients Stop Responding to Treatment

For patients diagnosed with aggressive blood cancers, receiving a proven targeted therapy offers a clear path toward a...